EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 28 January 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. 2.54 for October-December 2020 as against Tk. 1.89 for October-December 2019; Consolidated EPS was Tk. 4.95 for July-December 2020 as against Tk. 3.83 for July-December 2019. Consolidated NOCFPS was Tk. 4.91 for July-December 2020 as against Tk. 9.14 for July-December 2019. Consolidated NAV per share was Tk. 76.45 as on December 31, 2020 and Tk. 75.66 as on December 31, 2019.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400547a6
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.